Karachi: Lucky Core Industries Limited has released its Annual Report for the fiscal year 2025-26, revealing a challenging economic environment that led to a 6% decline in net turnover compared to the same period last year. The company reported a net turnover of PKR 113,214 million for the year, down from PKR 120,013 million in the previous year.
The report, dated September 3, 2026, highlighted the slowdown in demand across several business segments, including Polyester, Soda Ash, and Chemicals & Agri Sciences, which saw declines of 13%, 9%, and 1% respectively. Conversely, the Animal Health and Pharmaceuticals segments experienced growth, with net turnover increasing by 17% and 5% respectively.
The company's operating result for the year stood at PKR 14,704 million, reflecting an 18% reduction from the previous year. Strong performances in the Animal Health and Pharmaceuticals segments, which posted growth in operating results of 20% and 16% respectively, were overshadowed by significant declines in other segments. The Polyester segment, in particular, faced a 74% reduction in operating results.
According to information available from the Pakistan Stock Exchange (PSX), the decline in the operating result affected the company's overall profitability. Profit After Tax (PAT) was recorded at PKR 9,692 million, a 17% decrease from the previous year, mirroring the drop in operating results. This decline was largely attributed to weaker market conditions and increased finance costs, which rose by 13% due to higher borrowings.
Despite the challenging environment, Lucky Core Industries' Pharmaceuticals Business showed resilience, supported by an expanded product portfolio and improved operational efficiencies. In the Animal Health segment, increased demand for veterinary medicines was driven by a higher incidence of disease in key livestock regions.
The company's financial position remained robust, with total assets reaching PKR 102.30 billion as of June 30, 2026, up from PKR 95.10 billion the previous year. The current ratio improved to 1.59, and the quick ratio rose to 0.92, providing the company with financial flexibility to support ongoing operations and growth initiatives.
The Board of Directors recommended a final cash dividend of 262.5%, equating to PKR 5.25 per share, subject to approval at the forthcoming Annual General Meeting. This is in addition to the interim dividend already paid, bringing the total dividend for the year to PKR 10.50 per share.
During the year, the company inaugurated a veterinary medicine manufacturing facility in Sheikhupura and incorporated a wholly-owned offshore subsidiary, Lucky Core Investments Limited, in the Jebel Ali Free Zone. Additionally, the company completed a stock split, reducing the face value of its ordinary shares from PKR 10 to PKR 2 per share, with trading of the post-split shares commencing on the PSX in July 2025.